www.ecarepharmacy.com

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Lamivudine - Combivir, Epivir

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Combivir

Generic Combivir

Lamivudine - Zidovudine 150mg + 300mg

Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
More info »

$1.44 Buy now!
Epivir

Generic Epivir

Lamivudine 100/150mg

Generic Epivir is used for treating HIV infection in combination with other medicines.
More info »

$1.73 Buy now!
Choose Your language:
Social bookmarks:
Testimonials

I have rec'd the order, and was pleased with every aspect of the order. I do look forward to ordering in the future, so could you please keep in contact with me via this email.

Our billing is certified by:

Secure shopping certificates


Special Offer!

  • Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls

    Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.

  • Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times

    Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.

  • LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego

    LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.

  • Patent expires of landmark HIV drug Combivir - U-T San Diego

    Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.

  • South Africa exceeds 2007-11 treatment targets by 50% - aidsmap

    South Africa exceeds 2007-11 treatment targets by 50%aidsmapCrude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.